Literature DB >> 30178479

Systematic review of the screening, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the Task Force on Comorbidities of the ILAE Pediatric Commission.

Stéphane Auvin1, Elaine Wirrell2, Kirsten A Donald3, Madison Berl4, Hans Hartmann5, Kette D Valente6, Patrick Van Bogaert7, J Helen Cross8, Makiko Osawa9, Hideaki Kanemura10, Masao Aihara11, Marilisa M Guerreiro12, Pauline Samia13, Kollencheri Puthenveettil Vinayan14, Mary Lou Smith15, Lionel Carmant16, Michael Kerr17, Bruce Hermann18, David Dunn19, Jo M Wilmshurst20.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common and challenging comorbidity affecting many children with epilepsy. A working group under the International League Against Epilepsy (ILAE) Pediatric Commission identified key questions on the identification and management of ADHD in children with epilepsy. Systematic reviews of the evidence to support approaches to these questions were collated and graded using criteria from the American Academy of Neurology Practice Parameter. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) requirements were followed, with PROSPERO registration (CRD42018094617). No increased risk of ADHD in boys with epilepsy compared to girls with epilepsy was found (Level A). Valproate use in pregnancy is associated with inattentiveness and hyperactivity in offspring (1 class I study), and children with intellectual and developmental disabilities are at increased risk of ADHD (Level A). Impact of early seizure onset on development of ADHD was unclear (Level U), but more evident with poor seizure control (Level B). ADHD screening should be performed from 6 years of age, or at diagnosis, and repeated annually (Level U) and reevaluated after change of antiepileptic drug (AED) (Level U). Diagnosis should involve health practitioners with expert training in ADHD (Level U). Use of the Strength and Difficulties Questionnaire screening tool is supported (Level B). Formal cognitive testing is strongly recommended in children with epilepsy who are struggling at school (Level U). Behavioral problems are more likely with polytherapy than monotherapy (Level C). Valproate can exacerbate attentional issues in children with childhood absence epilepsy (Level A). Methylphenidate is tolerated and effective in children with epilepsy (Level B). Limited evidence supports that atomoxetine is tolerated (Level C). Multidisciplinary involvement in transition and adult ADHD clinics is essential (Level U). In conclusion, although recommendations could be proposed for some of the study questions, this systematic review highlighted the need for more comprehensive and targeted large-population prospective studies. Wiley Periodicals, Inc.
© 2018 International League Against Epilepsy.

Entities:  

Keywords:  antiepileptic drug; attention-deficit/hyperactivity disorder; children; epilepsy; methylphenidate; screening tools

Mesh:

Substances:

Year:  2018        PMID: 30178479     DOI: 10.1111/epi.14549

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Impact of Antiseizure Medications on Appetite and Weight in Children.

Authors:  Ersida Buraniqi; Hicham Dabaja; Elaine C Wirrell
Journal:  Paediatr Drugs       Date:  2022-05-21       Impact factor: 3.022

2.  Medical conditions and Attention-Deficit/Hyperactivity Disorder symptoms from early childhood to adolescence.

Authors:  Cédric Galéra; Samuele Cortese; Massimiliano Orri; Ophélie Collet; Judith van der Waerden; Maria Melchior; Michel Boivin; Richard E Tremblay; Sylvana M Côté
Journal:  Mol Psychiatry       Date:  2021-10-26       Impact factor: 15.992

3.  Uncovering Key Elements of an Executive Functioning Intervention in Adolescents: Epilepsy Journey.

Authors:  Ana M Gutierrez-Colina; Lisa Clifford; Shari L Wade; Avani C Modi
Journal:  Clin Pract Pediatr Psychol       Date:  2021-09-02

Review 4.  Psychiatric Comorbidities in People With Epilepsy.

Authors:  Marco Mula; Andres M Kanner; Nathalie Jetté; Josemir W Sander
Journal:  Neurol Clin Pract       Date:  2021-04

5.  The association between ADHD and physical health: a co-twin control study.

Authors:  Pei-Yin Pan; Sven Bölte
Journal:  Sci Rep       Date:  2020-12-28       Impact factor: 4.379

6.  Association of Perinatal and Childhood Ischemic Stroke With Attention-Deficit/Hyperactivity Disorder.

Authors:  Jenny Bolk; Eleni Simatou; Jonas Söderling; Lisa B Thorell; Martina Persson; Heléne Sundelin
Journal:  JAMA Netw Open       Date:  2022-04-01

Review 7.  Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.

Authors:  Beth A Leeman-Markowski; Jesse Adams; Samantha P Martin; Orrin Devinsky; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2020-12-24       Impact factor: 2.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.